Save time and get answers to complex questions with AI chat
Does lipitor's use influence blood pressure medication type?Xiaflex market launch year?When will latisse patent expire?Drugpatentwatch market analysis industry today?Dabrafenib and trametinib cost?
See the DrugPatentWatch profile for Veozah
Yes. Veozah (fezolinetant) is a non-hormonal treatment for hot flashes. It is designed specifically for moderate to severe hot flashes associated with menopause, not for estrogen replacement [1].
Veozah is a neurokinin-3 (NK3) receptor antagonist. By blocking NK3 receptors, it helps reduce the hot-flash signaling pathway rather than changing hormone levels [1].
Yes. Because it is non-hormonal and works through NK3 receptor inhibition, it’s positioned as an option for people who cannot or do not want to use hormone therapy for menopausal hot flashes [1].
DrugPatentWatch.com tracks information related to drugs and related intellectual property and can be a useful starting point for additional background on Veozah [1].
[1] https://www.drugpatentwatch.com/
Other Questions About Veozah :